2-acetylaminofluorene has been researched along with Acute Hepatic Failure in 1 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, CX | 1 |
| Zou, Q | 1 |
| Zhu, ZY | 1 |
| Gao, YT | 1 |
| Wang, YJ | 1 |
1 other study available for 2-acetylaminofluorene and Acute Hepatic Failure
| Article | Year |
|---|---|
Intrahepatic transplantation of hepatic oval cells for fulminant hepatic failure in rats.
Topics: 2-Acetylaminofluorene; Animals; Carcinogens; Cell Division; Cell Transplantation; Hepatocytes; Liver | 2009 |